首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1922540

日本神經調控市場報告：按技術、生物材料、應用和地區分類（2026-2034年）

Japan Neuromodulation Market Report by Technology, Biomaterial, Application, and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 119 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本神經調控市場規模達3.938億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到11.034億美元，2026年至2034年的複合年成長率（CAGR）為12.13%。推動日本市場成長的關鍵因素包括：人口老化加劇、近期技術進步、醫療費用支出增加、人們對神經調控益處的認知不斷提高、主要市場參與者的強大影響力以及優惠的報銷政策。

神經調控是一種透過向神經系統特定區域傳遞藥物或電刺激來調節神經活動的療法。神經調控有多種類型，包括脊髓刺激、深部腦部刺激、薦椎神經刺激和周邊神經刺激。神經調控設備由多個組件構成，包括脈衝產生器、電極和手持式程式設計設備。它們具有許多優勢，例如微創性、可自訂的治療設定和即時回饋機制。神經調控廣泛用於治療慢性疼痛、癲癇、運動障礙、精神疾病、偏頭痛和胃腸道疾病。與全身給藥相比，神經調控具有標靶治療、副作用更少、可逆性以及遠端患者監護等優勢。此外，它還具有許多益處，例如提高患者依從性、改善生活品質、長期成本效益以及能夠即時調整治療設定。

日本神經調控市場趨勢：

日本人口老化加劇，導致神經系統疾病和慢性疾病發生率上升，從而推動了市場成長。此外，無線神經調控技術的出現等近期技術進步，拓展了神經調控的應用範圍，進一步促進了市場成長。醫療費用支出的增加和神經系統研究日益受到重視，也推動了市場成長，為市場擴張創造了有利環境。此外，人們對神經調控益處的認知不斷提高，加快了其應用普及速度，進一步推動了市場成長。主要市場參與者在日本的強大影響力以及頻繁的新產品發布也刺激了市場成長。此外，政府醫療保健系統推出的針對神經調控手術的優惠報銷政策也推動了市場成長。臨床試驗不斷證實神經調控技術的有效性，進一步增強了人們對技術的信心，對市場成長產生了正面影響。同時，對微創手術的廣泛需求推動了神經調控技術的應用，支持了市場成長。因此，神經調控領域專業醫療人員數量的增加也推動了市場成長。此外，人工智慧（AI）在即時調整和監測方面的應用對市場成長產生了積極影響。同時，患者對神經調控的依從性和滿意度的提高，也帶動了患者轉診量的增加，進而推動了市場成長。此外，主要企業之間不斷增加的策略合作和收購，進一步拓展了研究並利用了共用的專業知識，從而增強了市場成長。此外，公共和私人部門對研發活動的投資不斷增加，也推動了市場成長。

本報告解答的關鍵問題：

日本神經調控市場目前發展狀況如何？您認為未來幾年它將如何發展？
新冠疫情對日本神經調控市場產生了哪些影響？
日本神經調控市場依技術分類的構成比是怎樣的？
日本生物材料神經調控市場的市場組成是怎樣的？
日本神經調控市場按應用領域是如何細分的？
日本神經調控市場價值鏈的不同階段有哪些？
日本神經調控市場的主要促進因素和挑戰是什麼？
日本神經調控市場的結構是怎麼樣的呢？主要參與者有哪些？
日本神經調控市場競爭有多激烈？

Japan neuromodulation market size reached USD 393.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,103.4 Million by 2034, exhibiting a growth rate (CAGR) of 12.13% during 2026-2034. The rising geriatric population in Japan, recent technological advancements, increasing healthcare expenditure, heightened awareness about the benefits of neuromodulation, strong presence of key market players, and introduction of favorable reimbursement policies represent some of the key factors driving the market.

Neuromodulation refers to a technology involving the modification of nerve activity by delivering pharmaceutical or electrical agents to targeted areas of the nervous system. It encompasses a wide range of types, including spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, and peripheral nerve stimulation. Neuromodulation is comprised of several components, such as a pulse generator, electrodes, and a handheld device for programming. It offers multiple features, including minimally invasive procedures, customizable treatment settings, and real-time feedback mechanisms. Neuromodulation is widely used for treating chronic pain, epilepsy, movement disorders, psychiatric conditions, migraines, and gastrointestinal issues. It offers targeted therapy, reduced side effects as compared to systemic drug administration, reversibility, and the potential for remote patient monitoring. Additionally, neuromodulation provides several advantages, such as enhanced patient compliance, better quality of life, cost-effectiveness in the long run, and the opportunity for real-time adjustments to treatment settings.

Japan Neuromodulation Market Trends:

The rising geriatric population in Japan, contributing to the escalating incidences of neurological and chronic disorders, is propelling the market growth. Additionally, recent technological advancements, such as the advent of wireless neuromodulation, that are expanding the technique's applications are driving the market growth. Besides this, the increasing healthcare spending and the prioritization of neurological research, fostering a conducive environment for market expansion, is acting as another growth-inducing factor. Furthermore, the heightened awareness about the benefits of neuromodulation, which is facilitating faster adoption rates, is catalyzing the market growth. In addition to this, the strong presence of key market players and frequent product launches in Japan is stimulating the market growth. Apart from this, the introduction of favorable reimbursement policies by the government healthcare system for neuromodulation procedures is bolstering the market growth. Moreover, the growing evidence of the efficacy of neuromodulation through clinical trials, lending further credence to the technology, is positively influencing the market growth. Along with this, the widespread demand for minimally invasive procedures, boosting neuromodulation applications, is supporting the market growth. In line with this, the escalating number of skilled healthcare professionals in the field of neuromodulation is driving the market growth. Furthermore, the integration of artificial intelligence (AI) for real-time adjustments and monitoring is creating a positive outlook for the market growth. In addition, the rising patient compliance and satisfaction rates with neuromodulation, encouraging more referrals, is accelerating the market growth. Besides this, the increasing strategic collaborations and acquisitions among key players to expand further research and leverage shared expertise are strengthening the market growth. Additionally, the growing public and private investment in research and development (R&D) activities is fueling the market growth.

Japan Neuromodulation Market Segmentation:

Technology Insights:

Internal Neuromodulation
- Spinal Cord Stimulation (SCS)
- Deep Brain Stimulation (DBS)
- Vagus Nerve Stimulation (VNS)
- Sacral Nerve Stimulation (SNS)
- Gastric Electrical Stimulation (GES)
External Neuromodulation
- Transcutaneous Electrical Nerve Stimulation (TENS)
- Transcranial Magnetic Stimulation (TMS)
- Others

Biomaterial Insights:

Metallic Biomaterials
Polymeric Biomaterials
Ceramic Biomaterials

Application Insights:

Parkinson's Disease
Epilepsy
Depression
Dystonia
Pain Management
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan neuromodulation market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan neuromodulation market?
What is the breakup of the Japan neuromodulation market on the basis of technology?
What is the breakup of the Japan neuromodulation market on the basis of biomaterial?
What is the breakup of the Japan neuromodulation market on the basis of application?
What are the various stages in the value chain of the Japan neuromodulation market?
What are the key driving factors and challenges in the Japan neuromodulation?
What is the structure of the Japan neuromodulation market and who are the key players?
What is the degree of competition in the Japan neuromodulation market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Neuromodulation Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Neuromodulation Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Neuromodulation Market - Breakup by Technology

6.1 Internal Neuromodulation
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Spinal Cord Stimulation (SCS)
  - 6.1.3.2 Deep Brain Stimulation (DBS)
  - 6.1.3.3 Vagus Nerve Stimulation (VNS)
  - 6.1.3.4 Sacral Nerve Stimulation (SNS)
  - 6.1.3.5 Gastric Electrical Stimulation (GES)
- 6.1.4 Market Forecast (2026-2034)
6.2 External Neuromodulation
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Segmentation
  - 6.2.3.1 Transcutaneous Electrical Nerve Stimulation (TENS)
  - 6.2.3.2 Transcranial Magnetic Stimulation (TMS)
  - 6.2.3.3 Others
- 6.2.4 Market Forecast (2026-2034)

7 Japan Neuromodulation Market - Breakup by Biomaterial

7.1 Metallic Biomaterials
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Polymeric Biomaterials
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Ceramic Biomaterials
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)

8 Japan Neuromodulation Market - Breakup by Application

8.1 Parkinson's Disease
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Epilepsy
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Depression
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)
8.4 Dystonia
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Forecast (2026-2034)
8.5 Pain Management
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Forecast (2026-2034)
8.6 Others
- 8.6.1 Historical and Current Market Trends (2020-2025)
- 8.6.2 Market Forecast (2026-2034)

9 Japan Neuromodulation Market - Breakup by Region

9.1 Kanto Region
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Breakup by Technology
- 9.1.4 Market Breakup by Biomaterial
- 9.1.5 Market Breakup by Application
- 9.1.6 Key Players
- 9.1.7 Market Forecast (2026-2034)
9.2 Kansai/Kinki Region
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Breakup by Technology
- 9.2.4 Market Breakup by Biomaterial
- 9.2.5 Market Breakup by Application
- 9.2.6 Key Players
- 9.2.7 Market Forecast (2026-2034)
9.3 Central/ Chubu Region
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Breakup by Technology
- 9.3.4 Market Breakup by Biomaterial
- 9.3.5 Market Breakup by Application
- 9.3.6 Key Players
- 9.3.7 Market Forecast (2026-2034)
9.4 Kyushu-Okinawa Region
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2020-2025)
- 9.4.3 Market Breakup by Technology
- 9.4.4 Market Breakup by Biomaterial
- 9.4.5 Market Breakup by Application
- 9.4.6 Key Players
- 9.4.7 Market Forecast (2026-2034)
9.5 Tohoku Region
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2020-2025)
- 9.5.3 Market Breakup by Technology
- 9.5.4 Market Breakup by Biomaterial
- 9.5.5 Market Breakup by Application
- 9.5.6 Key Players
- 9.5.7 Market Forecast (2026-2034)
9.6 Chugoku Region
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2020-2025)
- 9.6.3 Market Breakup by Technology
- 9.6.4 Market Breakup by Biomaterial
- 9.6.5 Market Breakup by Application
- 9.6.6 Key Players
- 9.6.7 Market Forecast (2026-2034)
9.7 Hokkaido Region
- 9.7.1 Overview
- 9.7.2 Historical and Current Market Trends (2020-2025)
- 9.7.3 Market Breakup by Technology
- 9.7.4 Market Breakup by Biomaterial
- 9.7.5 Market Breakup by Application
- 9.7.6 Key Players
- 9.7.7 Market Forecast (2026-2034)
9.8 Shikoku Region
- 9.8.1 Overview
- 9.8.2 Historical and Current Market Trends (2020-2025)
- 9.8.3 Market Breakup by Technology
- 9.8.4 Market Breakup by Biomaterial
- 9.8.5 Market Breakup by Application
- 9.8.6 Key Players
- 9.8.7 Market Forecast (2026-2034)

10 Japan Neuromodulation Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Services Offered
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Services Offered
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Services Offered
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Services Offered
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Services Offered
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Neuromodulation Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis